First-Of-Its-Kind Non-Human Wound Product Combines Mānuka Honey, Collagen Derivative, And Hydroxyapatite To Redefine ...

BioPharma SHAKTI aims to revolutionize biologics by promoting non-animal models for safer and more effective drug development ...

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company ...

(Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has received a minimum ...

Engineered tissue could eventually be used for children born with gaps in their alimentary canal, or for adults whose muscles ...

On March 19, 2026, Humacyte, Inc. entered into securities purchase agreements for a registered direct offering of 25,000,000 shares of common stock at $0.80 per share, for expected net proceeds of ...

Humacyte, Inc. (NASDAQ:HUMA) is one of the 11 Best High Volume Penny Stocks to Buy Now. On March 17, 2026, Humacyte, Inc.

Microplastics are all over the environment and even inside human bodies. Researchers have found a type of bioengineered algae ...

It's rare that a film adaptation outshines its source material but science fiction has given us several remarkable examples ...

In this article, we will look at the 11 Best High Volume Penny Stocks to Buy Now. After a prolonged period where mega-cap ...

India, March 22 -- Researchers at Great Ormond Street Hospital and University College London have successfully engineered a ...

This year, International Women's Day coincides with Endometriosis Awareness Month. Endometriosis is a common and painful ...